Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 363-367

  Fraisier, Christophe ^a   Arnarson, Hallgrimur ^b   Barbezange, Cyril ⁱ   Andrésdǒttir, Valgerdur ^b   Carrozza, Maria Luisa ^c   De Andrés, Damian ^d   Tolari, Francesco ^c   Rosati, Sergio ^e   Luján, Lluis ^f   Pépin, Michel ^g   Amorena, Beatriz ^d   Harkiss, Gordon ^h   Blacklaws, Barbara ⁱ   Suzan Monti, Marie ^a  

^a CNRS   (France)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF PISA   (Italy)

^d PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSIDAD DE ZARAGOZA   (Spain)

^g Healthy Pigs Production and Experimentation Section   (France)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

DNA vaccine; Envelope precursor protein; Maedi visna virus; Mammalian expression vector

Indexed keywords

PLASMID DNA; PROTEIN PRECURSOR; VACCINIA VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENVELOPE GENE; FOWL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRUS GENE; VISNA VIRUS; WESTERN BLOTTING;

ANIMALS; CELL LINE; GENE PRODUCTS, ENV; GENES, ENV; GENETIC VECTORS; HUMANS; PLASMIDS; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VACCINES, DNA; VIRAL VACCINES; VISNA; VISNA-MAEDI VIRUS;

AVES; EUKARYOTA; MAMMALIA; VISNA/MAEDI VIRUS;

EID: 35649020778     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.06.015     Document Type: Article

References (28)

1. Antoine G., Scheiflinger F., Dorner F., and Falkner F.G. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244 (1998) 365-396
2. Beyer J.C., Chebloune Y., Mselli-Lakhal L., Hotzel I., Kumpula-McWhirter N., and Cheevers W.P. Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein. Vaccine 19 (2001) 1643-1651
3. Boshoff C.H., Dungu B., Williams R., Vorster J., Conradie J.D., Verwoerd D.W., and York D.F. Detection of maedi-visna virus antibodies using a single fusion transmembrane-core p25 recombinant protein ELISA and a modified receiver-operating characteristic analysis to determine cut-off values. J. Virol. Methods 63 (1997) 47-56
4. Carey N., Roy D.J., and Dalziel R.G. Use of recombinant gp135 to study epitope-specific antibody responses to maedi visna virus. J. Virol. Methods 43 (1993) 221-232
5. Carter P., and Dalziel R.G. Expression of the SU glycoprotein of maedi visna virus in baculovirus. Arch. Virol. 142 (1997) 1563-1575
6. Cheevers W.P., Snekvik K.R., Trujillo J.D., Kumpula-McWhirter N.M., Pretty On Top K.J., and Knowles D.P. Prime-boost vaccination with plasmid DNA encoding caprine arthritis-encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis. Virology 306 (2003) 116-125
7. Cutlip R.C., Lehmkuhl H.D., Brogden K.A., and Schmerr M.J. Failure of experimental vaccines to protect against infection with ovine progressive pneumonia (maedi-visna) virus. Vet. Microbiol. 13 (1987) 201-204
8. Gao F., Li Y., Decker J.M., Peyerl F.W., Bibollet-Ruche F., Rodenburg C.M., Chen Y., Shaw D.R., Allen S., Musonda R., Shaw G.M., Zajac A.J., Letvin N., and Hahn B.H. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res. Hum. Retroviruses 19 (2003) 817-823
9. Gonzalez B., Reina R., Garcia I., Andres S., Glaria I., Alzueta M., Mora M.I., Jugo B.M., Arrieta-Aguirre I., de la Lastra J.M., Rodriguez D., Rodriguez J.R., Esteban M., Grillo M.J., Blacklaws B.A., Harkiss G.D., Chebloune Y., Lujan L., de Andres D., and Amorena B. Mucosal immunization of sheep with a maedi-visna virus (MVV) env DNA vaccine protects against early MVV productive infection. Vaccine 23 (2005) 4342-4352
10. Huso D.L. Neutralizing and fusion-blocking antibodies induced by recombinant visna virus envelope glycoprotein. Viral Immunol. 10 (1997) 15-20
11. Kumar S., Yan J., Muthumani K., Ramanathan M.P., Yoon H., Pavlakis G.N., Felber B.K., Sidhu M., Boyer J.D., and Weiner D.B. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol. 25 (2006) 383-392
12. Kwang J., and Cutlip R. Analysis of antibody response to ovine lentivirus by using viral gene products expressed in a prokaryotic system. Biochem. Biophys. Res. Commun. 188 (1992) 20-27
13. Kwang J., and Cutlip R. Detection of antibodies to ovine lentivirus using a recombinant antigen derived from the env gene. Biochem. Biophys. Res. Commun. 183 (1992) 1040-1046
14. Kwang J., Keen J., Cutlip R.C., and Littledike E.T. Evaluation of an ELISA for detection of ovine progressive pneumonia antibodies using a recombinant transmembrane envelope protein. J. Vet. Diagn. Invest. 5 (1993) 189-193
15. Kwang J., Kim H.S., Rosati S., and Lehmkuhl H.D. Characterization of ovine lentivirus envelope glycoprotein expressed in Escherichia coli cell and baculovirus systems. Vet. Immunol. Immunopathol. 45 (1995) 185-193
16. Lichtensteiger C.A., Knowles Jr. D.P., McGuire T.C., and Cheevers W.P. Recombinant gp135 envelope glycoproteins of caprine arthritis-encephalitis lentivirus variants inhibit homologous and heterologous variant-specific neutralizing antibodies. Virology 185 (1991) 2-9
17. McGuire T.C., Adams D.S., Johnson G.C., Klevjer-Anderson P., Barbee D.D., and Gorham J.R. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am. J. Vet. Res. 47 (1986) 537-540
18. Nathanson N., Martin J.R., Georgsson G., Palsson P.A., Lutley R.E., and Petursson G. The effect of post-infection immunization on the severity of experimental visna. J. Comp. Pathol. 91 (1981) 185-191
19. Power C., Richardson S., Briscoe M., and Pasick J. Evaluation of two recombinant maedi-visna virus proteins for use in an enzyme-linked immunosorbent assay for the detection of serum antibodies to ovine lentiviruses. Clin. Diagn. Lab. Immunol. 2 (1995) 631-633
20. Rafnar B., Tobin G.J., Nagashima K., Gonda M.A., Gunnarsson E., Andresson O.S., Georgsson G., and Torsteinsdottir S. Immune response to recombinant visna virus Gag and Env precursor proteins synthesized in insect cells. Virus Res. 53 (1998) 107-120
21. Rosati S., Kwang J., Tolari F., and Keen J. A comparison of whole virus and recombinant transmembrane ELISA and immunodiffusion for detection of ovine lentivirus antibodies in Italian sheep flocks. Vet. Res. Commun. 18 (1994) 73-80
22. Sanchez A.B., Rodriguez D., Garzon A., Amorena B., Esteban M., and Rodriguez J.R. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans. Arch. Virol. 147 (2002) 2377-2392
23. Sargan D.R., Bennet I.D., Cousens C., Roy D.J., Blacklaws B.A., Dalziel R.G., Watt N.J., and McConnell I. Nucleotide sequence of EV1, a British isolate of maedi-visna virus. J. Gen. Virol. 72 Pt 8 (1991) 1893-1903
24. Singh I., McConnell I., Dalziel R., and Blacklaws B.A. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity. Vet. Immunol. Immunopathol. 113 (2006) 357-366
25. Skraban R., Matthiasdottir S., Torsteinsdottir S., Agnarsdottir G., Gudmundsson B., Georgsson G., Meloen R.H., Andresson O.S., Staskus K.A., Thormar H., and Andresdottir V. Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype. J. Virol. 73 (1999) 8064-8072
26. Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tiollais P., Haase A., and Wain-Hobson S. Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell 42 (1985) 369-382
27. Vigne R., Filippi P., Querat G., Sauze N., Vitu C., Russo P., and Delori P. Precursor polypeptides to structural proteins of visna virus. J. Virol. 42 (1982) 1046-1056
28. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., and Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14 (2004) 1229-1246